Henan Splendor Science & Technology (002296.SZ) predicts a net profit of 247 million to 312 million yuan for the year 2024, a year-on-year increase of 50% to 90%.
Brilliant Technology (002296.SZ) releases the 2024 performance forecast, expecting the annual attributable to shareholders of the listed company to...
Henan Splendor Science & Technology (002296.SZ) released its performance forecast for 2024, expecting a net profit attributable to the shareholders of the listed company of 247 million to 312 million yuan for the full year, an increase of 50%-90% year-on-year. During the reporting period, the company continued to maintain a stable operating state, with many completed projects in its main business, resulting in an increase in operating income and overall performance growth compared to the same period last year.
Related Articles

MTR Corporation (00066): Kanzepei appointed as non-executive director.

Guiyang Xintian Pharmaceutical(002873.SZ): Xinkang Capsules approved to conduct clinical trials for the treatment of cancer-related fatigue.

TRUE PARTNER (08657) had assets under management of approximately $432 million at the end of September.
MTR Corporation (00066): Kanzepei appointed as non-executive director.

Guiyang Xintian Pharmaceutical(002873.SZ): Xinkang Capsules approved to conduct clinical trials for the treatment of cancer-related fatigue.

TRUE PARTNER (08657) had assets under management of approximately $432 million at the end of September.

RECOMMEND

Comprehensive Subsidy Phase-Out: Is China’s Auto Market Nervous Ahead of Golden Week?
30/09/2025

“A+H” Listing Momentum Continues as 20 A‑Share Companies Plan Hong Kong IPOs, PCB Leaders Dongshan Precision and Hoshine Among Them
30/09/2025

Copper Poised as the “New Oil” as Western Grids Lag Behind China, Goldman Sachs Warns
30/09/2025